Bill Gates estimated when countries will end the coronavirus pandemic

“This makes me feel like the rich world sure should be able to end (the pandemic) by the end of 2021, and the rest of the countries by the end of 2022.”said the mogul in an interview with Wired magazine.

The co-founder of the Microsoft company was optimistic about the effectiveness of a coronavirus vaccine: “This disease appears to be highly preventable with vaccines”. Right now, the Bill and Melinda Gates Foundation is funding medical research and vaccine programs.

On the other hand, Bill Gates believes that some vaccines in development are going to help the richest countries due to their way of production and the difficulty of distributing them, and stated: “They will not be a low-cost, scalable solution for the rest of the world.”

.

France with large increase in infected: 2524 more cases in one day

The number of new covid-19 infections in France has risen sharply with 2524 cases in the last 24 hours, well above the 1397 recorded on Tuesday, the country’s General Directorate of Health (DGS) said on Wednesday.

The evolution over the last week in the number of new people infected with covid-19 is upward, registering 11,663 cases, highlighted the DGS in a statement, cited by the agency EFE.

In a week, between 3 and 9 August, the positive rate also rose 2.2%, increasing one tenth compared to data released on Tuesday and following the trend seen in recent days.

In addition to these figures, France has accelerated testing, with a total of 606 487 in the last week.

On the official website on the Internet that tracks the evolution of the pandemic in that country, DGS has registered a total of 206 696 cases since the beginning of the pandemic.

There are currently 217 outbreaks of contagion to be monitored across the country, 25 more than the previous day.

Despite this, the number of patients hospitalized for the new coronavirus has decreased to 4891, from 5012 registered on Tuesday.

In the last 24 hours, 143 new hospitalizations took place and of all infected patients hospitalized, 379 are in intensive care units.

France still adds 18 more deaths in hospitals in 24 hours. DGS does not update the death toll outside hospitals every day.

In total, 30 371 people have died in France since March due to covid-19.

The French Government announced this Wednesday that it will increase the number of police officers so that the obligation to use masks is effectively fulfilled, a rule that is being implemented in more cities in areas where there is a greater concentration of people.

.

COVID-19: the sequelae “not worse than the flu”? False

We already know that the percentage of deaths from Covid-19 is superior to that of the flu. But for those who would still find this death rate uninteresting, what about the direct, long-term impacts of the disease, which set it apart from the seasonal flu? We take stock.

A direct effect: respiratory distress

In the majority of cases, the SARS-CoV-2 virus, which causes COVID-19, causes only a mild form of the disease. The lucky ones are rid of the virus after two to three weeks. But about one in five people develop severe symptoms that can lead to intensive care. We think in particular of the acute respiratory distress, linked to overreaction of the immune systeme. This complication sometimes occurred during an infection with the influenza virus (the flu), but it is much more common with the coronavirus.

In the end, the death rate fluctuates by region and by age category: several studies now point to a range oscillating between 0.5 and 1%, which remains much higher than for influenza.

More long-term effects

But even after the hospital, there are consequences. In 5-10% of patients cured of COVID-19, the slope is difficult to go up: they drag symptoms sometimes quite heavy for weeks, even months. These symptoms are not only respiratory, as specialists thought so in the beginning. Today, is a site that the disease can cause tachycardia, muscle and joint pain, and exhaustion more than 60 days after the onset of the disease.

Are also mentioned of neurological damage ranging from simple cognitive difficulties, fatigue or loss of taste or smell, to cases of headache, stroke and epilepsy. BBC reported that at the end of June, there were already more than 300 studies on these neurological abnormalities observed in patients with Covid-19.

People with residual symptoms now speak of their reality as « syndrome post COVID-19 ». They are also found by the thousands in online support groups. As the virus has only been known for seven months, it is not known how long these repercussions last. Follow-up studies carried out with victims of the SARS epidemic in 2002-2003 also reported lasting sequelae, such as exhaustion, of the Depression and an loss of respiratory function.

In comparison, influenza viruses cause much less damage. If various complications are possiblelike pneumonia, these are usually short-lived — less than 2 weeks.

Even in the case of two strains of influenza that have caught the imagination, H1N1 in 2009 and H7N9 in 2013, the long-term sequelae seem mostly respiratory. A study involving 22 survivors of severe pneumonia following influenza A (H1N1), concluded that a year after leaving intensive care, although all had recovered most of their lung function, there were differences between intubated patients life support and those who were not. A similar study involving 37 French survivors noted a measurable decrease in lung capacity one year after leaving intensive care.

Similar finding with the H7N9 influenza (A), which struck in Asia in 2013: a study published last March evokes permanent damage to their lungs a year after they were hospitalized. However, remember that the scale is not the same: for the H7N9, WHO identifies officially 1,500 laboratory-confirmed cases between 2013 and 2018, and some 650 deaths. By comparison, in mid-August, Covid-19 reached the 20 million officially reported cases around the world, in just seven months.

.

Kaiser Permanente participates in COVID-19 vaccine trial in Portland | News

PORTLAND, OR (KPTV) – Portland could become instrumental in fighting the COVID-19 pandemic, as clinical trials for a new vaccine could begin here as early as next week.

Kaiser Permanente in Portland is taking the reins on the research as the vaccine will be tested on thousands of people.

The vaccine is moving into the final stages of testing, with researchers moving closer to getting the vaccine on the market to bring the COVID-19 pandemic to an end.






KPTV image.


“I mean, really, we look around the world and the horrific impact this pandemic has had,” Britta Torgrimson-Ojerio with Kaiser Permanente Center for Health Research said. “The human toll, the social toll, the economic toll, and having an effective vaccine is really what we need to get us back to our normal lives.”

The Kaiser Permanente Center for Health Research will begin clinical trials over the next few weeks for the vaccine.

“Soon, we’ll be able to start looking at that data and start to really understand this particular vaccine,” Torgrimson-Ojerio said. “We need to compare it to a placebo, so compare it to basically nothing, to see if it actually is effective.”

The healthcare provider says Portland is one of four sites in the United States that plans to test around 1,400 patients. The trial will ultimately test the vaccine on 30,000 people around the world.

“What we want to see is that the safety continues to look really good for this and we can continue to understand how effective it is,” Torgrimson-Ojerio said.

This will be the final stages of testing, where researchers say they hope to understand how long the vaccine can prove to be effective. While the vaccine is in its final stage, there is no timeline yet for when it could potentially be available, Kaiser Permanente says.

“Everyone wants to do this as quickly as possible but then at the same time we really have to make sure that we have all the data we need and that we can really understand it,” Torgrimson-Ojerio said.

Kaiser Permanente says it will send emails and flyers to qualified members to see their interest in participating in the study. Portland’s researchers say they are excited to be a part of these trials and what they could mean on a global level.

Copyright 2020 KPTV-KPDX Broadcasting Corporation. All rights reserved.

.

They identify the first case of syndrome associated with COVID-19 on the island

Several weeks ago, a 6-year-old boy became the first case of Multisystemic Inflammatory Syndrome in minors in Puerto Rico, a disease associated with COVID-19, and that until last August 6 had affected some 570 children in the United States.

The minor, who was already discharged after receiving a multifactorial medical treatment at the hospital level, was infected with COVID-19 and later presented a condition that was later diagnosed as this new syndrome, informed the pediatric infectologist Sanet Torres.

According to the Center for Disease Control and Prevention, this disease can cause inflammation of various parts of the body, including the heart, lungs, kidneys, brain, skin, eyes, and gastrointestinal organs.

“Data from the United States indicate that this syndrome affects more Hispanic children, especially adolescents,” said Torres.

According to the infectologist, Recent Health data show that children from zero to 19 years old represent 10 to 11% of the cases confirmed by the molecular diagnostic test.

“There are more cases in those ages reaching emergency rooms,” said pediatrician Carmen Suárez.

Meanwhile, today the La Fortaleza Health Advisory Group met at the Department of Health to discuss the recommendations that will be issued to Governor Wanda Vázquez regarding the new administrative order that must enter into force on August 16 as part of the the government’s efforts to control the pandemic. El Nuevo Día learned that experts will recommend greater restrictions given the growing increase in cases.

.

An investigation reveals the influence of hematological alterations in COVID-19

An investigation of the Basque center CIC bioGUNE has revealed that the high accumulation of porphyrins and hematological alterations are relevant markers in the COVID-19, so correcting these values ​​could alleviate some of the symptoms of the most severe patients.

Porphyrins are natural chemicals in the body that help form many important substances, one of which is hemoglobin., the protein in red blood cells that carries oxygen in the blood.

The results of this research, published in the British Journal of Hematology, show that COVID-19 patients present an abnormal concentration of porphyrins in their serum, and help to understand the hematological alteration in cases of the disease, as reported this Thursday by the Basque research center.

Severely ill patients have an alteration in the blood, with accumulation of porphyrins, as a consequence of the disorder that is registered in the metabolism of the heme group and hemoglobin, a protein in red blood cells that carries oxygen in the blood from the respiratory organs to the tissues.

“The symptoms of COVID-19 were initially oriented to a pneumological disease. However, it has been seen that it is much more complex and that there is a series of very important hematological disorders”, Explained Óscar Millet, head of the Precision Medicine and Metabolism laboratory at CIC bioGUNE.

One of these alterations is the lack of oxygen, which is not perceived and is believed to be due to a hormonal problem. “Severe COVID-19 patients have a lack of oxygen in their blood, although they do not notice that it is difficult for them to breathe. The hard part is that infected people eventually drown ”, she stressed.

This symptom of lack of oxygen led this research group from the CIC bioGUNE to suggest that there could be a disorder in the metabolism of hemoglobin itself.

The finding, according to the research center, will help to better understand what can be done to improve symptoms in seriously ill patients affected by the coronavirus.

The body of COVID-19 patients, detecting that they lack hemoglobin, tries to produce more, which causes an accumulation. “Identifying this accumulation of porphyrin markers is one more sign of the disease, and correcting these values ​​could alleviate some of the symptoms of the most serious patients”, highlighted Millet.

The research has been funded with a grant of more than 100,000 euros granted by the Department of Economic Development and Infrastructures of the Basque Government through the special call for research on COVID-19.

The work is part of the doctoral thesis of the researcher Itxaso San Juan, and Ganeko Bernardo, Maider Bizkarguenaga, Chiara Bruzzone, Nieves Embade and Óscar Millet himself have participated in the research, along with José María Mato, general director of the CIC bioGUNE.

To carry out the research, the team led by Óscar Millet, has used the serum of 300 seriously ill, symptomatic patients confirmed by a PCR test, from the Hospital Universitario de Cruces and the Hospital Universitario de Basurto.

.

152,200 candidates for Philo this Wednesday, the health protocol respected

“As part of the protocol, it was expected that the students and teachers, they are Senegalese, can naturally be positive. Without doubt, perhaps, there are. All teachers who are sick, I don’t even say sick with covid-19, but have a co-morbid condition, have been exempted from taking the exam.

For the students too, we have candidates. Whenever we are informed that a candidate is not available because of such or such a valid reason, he falls within the scope of those who are eligible for the remedial session.

The students have always been one per table. So the distance has always been observed. Now what is added to it is that for the recovery, there was already the health protocol which enacts a certain number of behaviors and acts to be performed, when one is at school. Now, it will be in the continuity of this that the examinations will take place. ”

.

Companies: | Who are now the new owners of Semana Económica? | sale | and

Change of rudder. Semana Económica, part of the company Perú Economico passed into the hands of other owners. The operation, which was closed a few hours ago, involves the transfer of 100% of shares, for an amount that they preferred not to disclose.

The information that the publication gave through its website was that “the buyers have vast experience in strategic consulting, market research, investment banking and financial advisory services, and they are mostly also partners of Aurum Capital and Mercados & Regions ”, by appointment.

But exactly to whom did the company pass? The shareholding was made up of 60% of shares that were owned by Corporación Radial del Perú (CRP) and 40% by Gonzalo Zegarra Mulanochiv. According to Management was able to learn after talking with one of those involved in the operation, in total there have been seven buyers. Of these, six that are linked to Aurum Capital and Mercados y Regiones magazine have made 60% and 40% are concentrated in an investor.

It should be noted that one of the new shareholders runs a business magazine in the White City.

The sale proposal came into the hands of the new owners in March of this year and yesterday the transfer of money for the purchase of Peru Economico was closed.

After that, what is expected is that from next Monday they will begin to see the management of the magazine itself.

“The idea at first is to exploit the online platform. The price has been attractive for the operation, especially in a period of pandemic ”, indicated another source linked to the operation, in addition to specifying that since the end of last year a possibility of sale was already being seen.

Now, what is sought is to leverage and increase the number of subscribers and among the plans is also to launch other products that go with the brand’s seal. This does not refer only to new publications but to be able to develop events, among other innovations.

Although it is not on the immediate horizon, it has not been ruled out that the online publication could reach other destinations.

As it became known, on the side of the vendors the company that advised them was UNE Asesores.

.

The ‘Zurdo’ López underwent a catheterization and it is studied if they should operate

The former Junior Technician Miguel Ángel López was hospitalized last Monday morning at the Clínica del Caribe, after feeling discomfort and abnormal pressure.

The news was known through social networks, after one of his pupils in the rojiblanco team, former striker Martín Arzuaga, reported his health status through Twitter.

“Let us put in our prayers Professor Miguel Ángel López, who suffered an acute myocardial infarction,” wrote the ‘Toro’.

Until the closing of this edition, no official medical report was known about the state of health of the ‘Zurdo’.

The Argentine, champion with the Sharks in 2004, has been based in Barranquilla for several years.

Francisco Arias, who works as López’s assistant, assures that the 78-year-old veteran helmsman “is stable, calm and in good spirits”, waiting for what the doctors decide.

“Still under observation. They’ve already had a catheterization that resulted in a clogged artery. The possibility of open heart surgery or another type of intervention is being studied, ”Arias told EL HERALDO.

The former technician, according to Arias, remains in constant communication with those closest to him. His relatives in Argentina have already been informed and are aware of his health, like many of Junior’s fans who have a feeling of admiration and gratitude for the star he helped embroider on the shield in 2004.

In dialogue with EL HERALDO, a few months ago, ‘El Zurdo’ had sent a message of affection and gratitude to the rojiblanca fans, in the midst of confinement due to the coronavirus pandemic.

“I want to thank you for the affection that I always receive. I miss you. Thank you for making my days happy, ”said the historic Argentine coach at the time.

Miguel Ángel López was the coach of Junior’s fifth star in the second half of 2004, in that remembered final against Atlético Nacional, where the rojiblancos won 3-0 in the first leg, in Barranquilla, and then fell 5-2 in Medellín , saving himself in the last minutes with the remembered goal of Argentine defender Walter Ribonetto. The Sharks prevailed on penalties 5-4.

He directed the Barranquilla team on seven occasions. Without a doubt, he is a character that is 100% linked to junior history.

‘El Zurdo’ made his debut as a professional footballer at the University of Córdoba in 1962 and retired in 1975 at Atlético Nacional, a club where he made his debut as a coach a year later.

During his long coaching career, he has twice managed América de México, with whom he won two league titles in 1985 and a Concacaf Champions League in 1992.

He was also in the Independiente de Avellaneda, with which he raised the title of the South American Super Cup in 1995, and also in the Argentine Boca Juniors, Rosario Central, Ferro Carril Oeste and Arsenal.

He also went through the Mexican Chivas de Guadalajara, Santos Laguna, Toluca, León, Atlético Celaya and Puebla, as well as Al-Ahli from Saudi Arabia and Badajoz from Spain.

.

Latam passenger traffic fell 93.4% in July

In the case of Chile, domestic transfers fell 94.4% to 114 thousand people.

Latam Airlines Group yesterday delivered its preliminary monthly traffic statistics for July 2020, figures that are compared to the same period in 2019, where there is still no evidence of a rebound in activity.

In the report, the company revealed that passenger traffic – measured in revenue per passenger kilometer (RPK) – decreased 93.4%, with a transfer of 733 thousand people, compared to 11.1 million a year ago. Meanwhile, capacity fell 88.5%.

As a result, occupancy decreased 35.9 percentage points to 48.5%. Meanwhile, international traffic represented about 26% of the total movement of travelers in the month.

In the breakdown, the airline pointed out that, in the case of its hub in Santiago de Chile, domestic traffic fell 94.4% to 114 thousand people. In the case of local flights in Brazil -whose subsidiary joined Chapter 11 in July-, the movement fell 85.6% from almost 3 million travelers to only 432 thousand. Now, compared to May, in the latter country, a significant increase in transfers can be seen.

In the accumulated of the year, the firm moved 30.63 million passengers, far from the 72 million in the same month of 2019.

For cargo transportation, Latam reported a 22.5% decrease in tons handled. This translates into 224 thousand tons; in addition to a reduction in capacity of 45.3%.

In the seven months, cargo fell 13%, equivalent to 1.77 million tons transported.



.